DK0635014T3 - Indolderivater som 5-HT1-lignende agonister - Google Patents

Indolderivater som 5-HT1-lignende agonister

Info

Publication number
DK0635014T3
DK0635014T3 DK93906620.5T DK93906620T DK0635014T3 DK 0635014 T3 DK0635014 T3 DK 0635014T3 DK 93906620 T DK93906620 T DK 93906620T DK 0635014 T3 DK0635014 T3 DK 0635014T3
Authority
DK
Denmark
Prior art keywords
pct
date oct
sec
optionally substituted
agonists
Prior art date
Application number
DK93906620.5T
Other languages
Danish (da)
English (en)
Inventor
John Eugene Macor
Martin James Wythes
Original Assignee
Pfizer Ltd
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd, Pfizer Res & Dev filed Critical Pfizer Ltd
Application granted granted Critical
Publication of DK0635014T3 publication Critical patent/DK0635014T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93906620.5T 1992-04-10 1993-03-25 Indolderivater som 5-HT1-lignende agonister DK0635014T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929207930A GB9207930D0 (en) 1992-04-10 1992-04-10 Indoles

Publications (1)

Publication Number Publication Date
DK0635014T3 true DK0635014T3 (da) 1996-02-12

Family

ID=10713831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93906620.5T DK0635014T3 (da) 1992-04-10 1993-03-25 Indolderivater som 5-HT1-lignende agonister

Country Status (16)

Country Link
US (1) US5639779A (de)
EP (1) EP0635014B1 (de)
JP (1) JP2784265B2 (de)
CN (1) CN1082039A (de)
AT (1) ATE133169T1 (de)
AU (1) AU3752593A (de)
CA (1) CA2131000C (de)
DE (1) DE69301357T2 (de)
DK (1) DK0635014T3 (de)
ES (1) ES2082639T3 (de)
FI (1) FI111255B (de)
GB (1) GB9207930D0 (de)
GR (1) GR3019132T3 (de)
IL (1) IL105311A0 (de)
WO (1) WO1993021177A1 (de)
ZA (1) ZA932534B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
DK0716649T3 (da) * 1993-08-31 1999-02-08 Pfizer 5-Arylindolderivater
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
GB9923314D0 (en) * 1999-10-01 1999-12-08 Pfizer Ltd Acylation process
EP1132389A1 (de) * 2000-03-06 2001-09-12 Vernalis Research Limited Neue Azaindolyl-Derivate für die Behandlung von Fettleibigheit
WO2011089614A1 (en) 2010-01-19 2011-07-28 Sms Pharmaceuticals Limited PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM
WO2025104491A1 (en) 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
NL8103764A (nl) * 1980-08-12 1982-03-01 Glaxo Group Ltd Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
PL170330B1 (pl) * 1990-10-15 1996-11-29 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
US5409941A (en) * 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives

Also Published As

Publication number Publication date
CA2131000C (en) 1998-09-22
GB9207930D0 (en) 1992-05-27
AU3752593A (en) 1993-11-18
US5639779A (en) 1997-06-17
DE69301357D1 (de) 1996-02-29
ATE133169T1 (de) 1996-02-15
WO1993021177A1 (en) 1993-10-28
GR3019132T3 (en) 1996-05-31
JP2784265B2 (ja) 1998-08-06
EP0635014B1 (de) 1996-01-17
FI111255B (fi) 2003-06-30
FI944727L (fi) 1994-10-07
JPH07505402A (ja) 1995-06-15
ES2082639T3 (es) 1996-03-16
IL105311A0 (en) 1993-08-18
FI944727A0 (fi) 1994-10-07
CA2131000A1 (en) 1993-10-28
EP0635014A1 (de) 1995-01-25
ZA932534B (en) 1994-10-08
CN1082039A (zh) 1994-02-16
DE69301357T2 (de) 1996-06-13

Similar Documents

Publication Publication Date Title
DK0635014T3 (da) Indolderivater som 5-HT1-lignende agonister
NO960365D0 (no) Perhydroisoindolderivater som substans-P-antagonister
CA2157397A1 (en) Indole derivatives as 5-ht1-like agonists for use in migraine
ATE92057T1 (de) Indol-derivate.
DK391289D0 (da) Indolderivater
NO970349L (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT inhibitorer
NO943261L (no) Indolderivater som 5-HT, agonister
DE69323667D1 (de) 4-substituierte 1,2,4-Triazolderivate
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
NO179865C (no) Nytt -fenylisoserinderivat og dets fremstilling
DK0785933T3 (da) Indolderivater som 5HT1-lignende agonister
DK0646110T3 (da) N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
DE69004989D1 (de) Indolderivate.
DK0514267T3 (da) Hidtil ukendte amidderivater af 1-aminooctahydropyrido(2,1-c)(1,4)oxazin, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
CA2350089A1 (en) Indole derivatives